JACC
HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
 QUICK SEARCH:   [advanced]


     


J Am Coll Cardiol, 2002; 39:804-810
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yamani, M. H.
Right arrow Articles by Young, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamani, M. H.
Right arrow Articles by Young, J. B.

CLINICAL STUDY: HEART TRANSPLANT

The role of vitronectin receptor ({alpha}vß3) and tissue factor in the pathogenesis of transplant coronary vasculopathy

Mohamad H. Yamani, MD*||,*, Carolina S. Masri, MD*||, Norman B. Ratliff, MD{dagger}, Meredith Bond, PhD{ddagger}, Randall C. Starling, MD, MPH, FACC*||, E. Murat Tuzcu, MD*, Patrick M. McCarthy, MD§|| and James B. Young, MD, FACC*||

* Department of Cardiology, Learner Research Institute, Cleveland, Ohio, USA
{dagger} Department of Anatomic Pathology, Learner Research Institute, Cleveland, Ohio, USA
{ddagger} Department of Molecular Cardiology, Learner Research Institute, Cleveland, Ohio, USA
§ Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA
|| Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, Ohio, USA

Manuscript received May 4, 2001; revised manuscript received November 28, 2001, accepted December 12, 2001.

* Reprint requests and correspondence: Dr. Mohamad H Yamani, Cleveland Clinic Foundation, Cardiology, F25, Heart Failure/Transplant Section, 9500 Euclid Avenue, Cleveland, Ohio 44195, USA.
yamanim{at}ccf.org

OBJECTIVES: This study was undertaken to test the hypothesis that transplant coronary vasculopathy (CV) is associated with increased myocardial protein expression of both tissue factor (TF) and integrin {alpha}vß3.

BACKGROUND: The vitronectin receptor (integrin {alpha}vß3) and TF have recently been found to play a key role in apoptotic cell death and vascular endothelial cell injury.

METHODS: A total of 77 heart transplant recipients underwent simultaneous endomyocardial biopsy and intravascular ultrasound (IVUS) at one year of transplant. Patients with pre-existing donor coronary atherosclerosis (n = 35) or with acute rejection (grade >1A, n = 10) at the time of the IVUS were excluded from the analysis. The remaining 32 patients constitute the cohort of the present study. A computerized biopsy score was derived based on the duration and severity of cellular rejection. Both TF and {alpha}vß3 expression in the heart biopsy specimens were evaluated by immunoperoxidase histochemistry and Western blot analysis.

RESULTS: Patients with CV (n = 24) had increased expression of {alpha}vß3 (2.7-fold, p = 0.003) and TF (7.9-fold, p = 0.04) compared with patients without evidence of vasculopathy (n = 8). In the absence of myocardial fibrosis, {alpha}vß3 expression correlated significantly with the cellular rejection score (r = 0.58, p = 0.02).

CONCLUSIONS: Transplant vasculopathy is associated with increased expression of both TF and {alpha}vß3. The significant correlation of {alpha}vß3 with cellular rejection suggests an important role for this integrin in serving as a mechanistic link between cellular rejection and vasculopathy.

Abbreviations and Acronyms
  GAPDH
  CMIT
  coronary maximal intimal thickness
  CV
  coronary vasculopathy
  GAPDH
  glyceraldehyde-3-phosphate dehydrogenase
  IVUS
  intravascular ultrasound
  TF
  tissue factor
  VSMC
  vascular smooth muscle cell




This article has been cited by other articles:


Home page
CJASNHome page
A. Chandrakantan, D. H. McDermott, H. T. Bich Tran, M. Jurewicz, L. Gallon, R. Gaston, E. Milford, and R. Abdi
Role of {beta}3 Integrin in Acute Renal Allograft Rejection in Humans
Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1268 - 1273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
J. Bedke, E. Kiss, C.-L. Behnes, Z. V. Popovic, M. Heuser, T. Stojanovic, T. Sijmonsma, P. Huber, S. Domhan, S. Muschal, et al.
Anti-Inflammatory Effects of {alpha}v Integrin Antagonism in Acute Kidney Allograft Rejection
Am. J. Pathol., October 1, 2007; 171(4): 1127 - 1139.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Mehra, P. A. Uber, D. Walther, M. Vesely, J. G. Wohlgemuth, J. Prentice, D. Tayama, and M. Billingham
Gene Expression Profiles and B-Type Natriuretic Peptide Elevation in Heart Transplantation: More Than a Hemodynamic Marker
Circulation, July 4, 2006; 114(1_suppl): I-21 - I-26.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Yousufuddin, S. Haji, R. C. Starling, E. M. Tuzcu, N. B. Ratliff, D. J. Cook, A. Abdo, Y. Saad, S. S. Karnik, D. Wang, et al.
Cardiac angiotensin II receptors as predictors of transplant coronary artery disease following heart transplantation
Eur. Heart J., March 1, 2004; 25(5): 377 - 385.
[Abstract] [Full Text] [PDF]




HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK
Copyright © 2002 by the American College of Cardiology Foundation.